Reply
- PMID: 34001819
- DOI: 10.1097/IAE.0000000000003212
Reply
Comment on
-
COMPARISON OF INTRAVITREAL DEXAMETHASONE IMPLANT AND AFLIBERCEPT IN PATIENTS WITH TREATMENT-NAIVE DIABETIC MACULAR EDEMA WITH SEROUS RETINAL DETACHMENT.Retina. 2020 Jun;40(6):1044-1052. doi: 10.1097/IAE.0000000000002537. Retina. 2020. PMID: 30950970 Clinical Trial.
-
Correspondence.Retina. 2021 Sep 1;41(9):e64-e65. doi: 10.1097/IAE.0000000000003211. Retina. 2021. PMID: 34001818 No abstract available.
References
-
- Ozsaygili C, Duru N. Comparison of intravitreal dexamethasone implant and aflibercept in patients with treatment-naive diabetic macular edema with serous retinal detachment. Retina 2020;40:1044–1052.
-
- Muralidhar A. Letter to the editor re: comparison of intravitreal dexamethasone implant and aflibercept in patients with treatment-naive diabetic macular edema with serous retinal detachment. Retina 2020;40:1044–1052.
-
- Velez-Montoya R, Fromow-Guerra J, Burgos O, et al. The effect of unilateral intravitreal bevacizumab (avastin), in the treatment of diffuse bilateral diabetic macular edema: a pilot study. Retina 2009;29:20–26.
-
- Avery RL, Pearlman J, Pieramici DJ, , et al, . Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 2006;113:1695.e1–15.
-
- Bakbak B, Ozturk BT, Gonul S, Gedik S. The effect of intravitreal bevacizumab and ranibizumab on macular edema of the contralateral eye: a comparative study of two anti-VEGFs. Oman J Ophthalmol 2016;9:44–48.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
